News Summary: Merck suspends Tredaptive sales

Published on NewsOK Modified: January 11, 2013 at 10:43 am •  Published: January 11, 2013
Advertisement
;

SUSPECT MEDICINE: Merck & Co. is suspending sales of the cholesterol drug Tredaptive after initial results from a study showed that it wasn't effective and could raise the risk of some serious side effects.

WHO'S AFFECTED: The tablets aren't approved in the United States, but they are sold in about 40 countries, including in Europe.

WHAT WENT WRONG: Merck says the side effects were not fatal and fell into several broad categories: blood and lymphatic, gastrointestinal, infections, metabolism, musculoskeletal, respiratory and skin.



Trending Now


AROUND THE WEB

  1. 1
    OKC Thunder: Pau Gasol tweets he's close to decision
  2. 2
    Police investigating dead body found in NE Oklahoma City
  3. 3
    At Tour de France, Safety Concerns Arise About Selfies
  4. 4
    The endless, excruciating idiocy of the Internet — in one very stupid viral photo
  5. 5
    How did Sports Illustrated land the LeBron James story?
+ show more